Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Public Reimbursement Policies for Oncology Medicines in Canada

What Is the Issue? Oncology medications can be broadly classified into treatments that are administered in a hospital and treatments that can be taken in the home setting. In Canada, public drug plan reimbursement for oncology medication varies between federal, provincial, and territorial (FPT) jurisdictions, and d...

Cda-Amc · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.